1
|
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.
|
Blood
|
2004
|
2.89
|
2
|
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
|
Biol Blood Marrow Transplant
|
2006
|
1.86
|
3
|
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.
|
Blood
|
2003
|
1.79
|
4
|
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor.
|
Blood
|
2005
|
1.24
|
5
|
Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses.
|
Transplantation
|
2010
|
1.10
|
6
|
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.
|
Transplantation
|
2011
|
0.91
|
7
|
Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.
|
Transpl Immunol
|
2012
|
0.84
|
8
|
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.
|
Blood
|
2006
|
0.84
|
9
|
Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.
|
Transplantation
|
2016
|
0.80
|
10
|
Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports.
|
Clin Transpl
|
2009
|
0.80
|
11
|
Expansion and somatic hypermutation of B-cell clones in rejected human kidney grafts.
|
Transplantation
|
2014
|
0.77
|
12
|
Dynamics of B cell recovery following kidney/bone marrow transplant recipients.
|
Transplantation
|
2017
|
0.75
|
13
|
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.
|
Eur J Haematol
|
2008
|
0.75
|
14
|
New answers to old conundrums: what antibodies, exosomes and inflammasomes bring to the conversation. Canadian National Transplant Research Program international summit report.
|
Transplantation
|
2017
|
0.75
|